PE-Backed Clinical Trials Co. Medpace Files $150 IPO
Medpace Holdings Inc., a private equity-backed contract research organization that provides clinical services for the drug and medical device industries, filed for a $150 million initial public offering on Friday, marking...To view the full article, register now.
Already a subscriber? Click here to view full article